HealthQuill Skin
France’s Sanofi SA will acquire US-based Blueprint Medicines Corporation for $9.1 billion to gain access to an immunology medicine for a rare disease and expand the company’s portfolio.
Drugs Health Pharma

Sanofi to acquire Blueprint for $9.1b for immunology medicine

HQ Team June 2, 2025: France’s Sanofi SA will acquire US-based Blueprint Medicines Corporation for $9.1 billion to gain access to an immunology.

Read More